Back to search

Efficacy and safety of human papillomavirus vaccine for primary prevention of cervical cancer: A review of evidence from phase III trials and national programs

Data up to Jan 2025

Published2013
Citations41
References22

Total Citations Per Year

Abstract

References (22)

Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

2003 • 6,072 citations

The causal relation between human papillomavirus and cervical cancer

2002 • 3,451 citations

Against which human papillomavirus types shall we vaccinate and screen? the international perspective

2004 • 1,099 citations

Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study

2008 • 1,039 citations

E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway.

1996 • 904 citations

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

2011 • 822 citations

Immune responses to human papillomavirus

2005 • 559 citations

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

2004 • 541 citations

The Human Papillomavirus E6 protein and its contribution to malignant progression

2001 • 514 citations

Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

2011 • 314 citations

The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme

2011 • 250 citations

Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink

2011 • 218 citations

Efficacy and other milestones for human papillomavirus vaccine introduction

2004 • 214 citations

Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine

2011 • 155 citations

Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study

2013 • 133 citations

Modifiable Risk Factors Associated with Clearance of Type-Specific Cervical Human Papillomavirus Infections in a Cohort of University Students

2005 • 92 citations

Understanding long‐term protection of human papillomavirus vaccination against cervical carcinoma: Cancer registry‐based follow‐up

2012 • 40 citations

MassARRAY Spectrometry Is More Sensitive than PreTect HPV-Proofer and Consensus PCR for Type-Specific Detection of High-Risk Oncogenic Human Papillomavirus Genotypes in Cervical Cancer

2011 • 32 citations

Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe?

2013 • 30 citations

Death after Quadrivalent Human Papillomavirus (HPV) Vaccination:Causal or Coincidental?

2016 • 22 citations

Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe?

2013 • 10 citations

Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study

2013 • 5 citations

Cited By (0)

No citing papers found in database

Efficacy and safety of human papillomavirus vaccine for primary prevention of cervical… (2013) – South Asian Journal of Cancer | Metascience Observatory Explorer